Results 31 to 40 of about 10,856 (235)

Myxedema Coma: A Rare Case of Shock Post-Pericardial Window Procedure

open access: yesClinical Medicine Insights: Cardiology, 2022
The clinical features of severe hypothyroidism vary in presentation, ranging from subclinical symptoms to multiorgan failure referred to as myxedema coma. The cornerstone treatments of myxedema coma include aggressive thyroid hormone replacement combined
Blerina Asllanaj   +2 more
doaj   +1 more source

Myxedema Coma: Case Report and Literature Review

open access: yesCureus, 2021
Myxedema coma is a life-threatening manifestation of hypothyroidism associated with altered mental status, hypothermia, and symptoms related to the slowing of other organ systems. It can occur as a culmination of severe, longstanding hypothyroidism or be
S. Elkattawy   +4 more
semanticscholar   +1 more source

Local immune microenvironment of skin may play an important role in the development of pretibial myxedema

open access: yesExperimental Dermatology, 2021
Pretibial myxedema (PTM), characterized by the accumulation of glycosaminoglycans in dermis is an autoimmune skin disorder, which is almost always associated with Graves’ disease (GD).
Xiaoying Chen   +6 more
semanticscholar   +1 more source

Severe hypoxemia after extubation secondary to myxedema coma: a case report

open access: yesJournal of International Medical Research, 2023
Myxedema coma is a rare and life-threatening endocrine emergency characterized by abnormalities in multiple organ systems. A 32-year-old woman with prolonged undiagnosed severe hypothyroidism was referred to our hospital owing to lower abdominal pain and
Jintao Sun   +4 more
doaj   +1 more source

Sudden Cardiac Arrest in a Patient With Myxedema Coma and COVID-19

open access: yesJournal of the Endocrine Society, 2020
SARS-CoV-2 infection is associated with significant lung and cardiac morbidity but there is a limited understanding of the endocrine manifestations of coronavirus disease 2019 (COVID-19).
Neal M. Dixit   +8 more
semanticscholar   +1 more source

Oral Levothyroxine is an Effective Option for Myxedema Coma: A Single-Centre Experience

open access: yesEuropean Thyroid Journal, 2020
Introduction: Myxedema coma is an endocrine emergency with a very high mortality rate. As per the American Thyroid Association, initial thyroid hormone replacement for myxedema coma should be intravenous levothyroxine (LT4).
Arjun Rajendran   +5 more
semanticscholar   +1 more source

Myxedema Coma Associated with Macroprolactinoma: Case Report and Review of the Literature

open access: yesCase Reports in Endocrinology, 2022
Myxedema coma is a rare life-threatening presentation of severe hypothyroidism associated with a high mortality rate. Although most cases are due to primary thyroid failure, a minority have central hypothyroidism as the underlying cause.
Elizabeth Jasola Omoniyi   +1 more
doaj   +1 more source

Pediatric Myxedema Coma – presenting as Surgical Abdomen

open access: yesJournal of Pediatric Critical Care, 2018
Myxedema com, also called myxedema crisis is a rare life threatening clinical condition that represents severe hypothyroidism. It may be the initial presentation in pediatric patients with prolonged untreated hypothyroidism.
G V Basavaraj   +2 more
doaj   +1 more source

Myxedema coma complicated by bilateral hygromas

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2021
Myxedema coma is an important differential diagnosis in critically ill patients. Early diagnosis and treatment are paramount but challenging due to a lack of diagnostic criteria. We report a case about a patient who suffered from untreated hypothyroidism
Ann-Elin Meling Stokland   +4 more
doaj   +1 more source

Look into hypothermia and hyponatremia in a myxedema coma case

open access: yesJournal of Clinical and Translational Endocrinology Case Reports, 2023
Background/objective: Given high mortality rates, understanding the management of associated hypothermia and hyponatremia in the myxedema coma remains crucial.
Amrit Pathak   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy